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ScienceDirectDistal axons, remote from their cell bodies and nuclei, must
survive the lifetime of an organism. Recent studies have
provided compelling evidence that proteins are locally
synthesized in healthy, mature central nervous system axons
and presynaptic terminals in vivo. Presynaptic, mitochondrial
and ribosomal proteins are locally synthesized in most adult
axons of diverse cell types, linking local translation to axon
function and survival. Accordingly, inhibiting the intra-axonal
translation of key mRNAs or the function of their translational
regulators causes dying-back axon degeneration, and human
mutations in RNA metabolic pathways are increasingly being
associated with neurodegenerative diseases that accompany
axon degeneration. Here, we summarize recent relevant
findings in a highly simplified ‘RNA operon’-based model and
discuss open questions and future directions.
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Introduction
Neurons in our brains live for several decades with a long
axon, where proteins have to be replenished throughout
the lifetime. Prompt and on-demand protein delivery
from the soma to the distal axon is a challenge particularly
in the meter-long axons of motor neurons, because it can
take over ten days even in a non-stop, full-speed journey
(reviewed in Ref. [1]). Nonetheless, anterograde protein
transport is a key mechanism and has received well-
deserved attention in cell biology and biology of neuro-
degeneration (reviewed in Ref. [2]). On-site protein
synthesis has been regarded as an additional and perhaps
exceptional mechanism, operating mainly in the devel-
oping and regenerating axons. Indeed, local mRNAwww.sciencedirect.com translation has been implicated in almost all aspects of
axon development, such as axon guidance, elongation,
target selection and survival (reviewed in Ref. [3]), and in
axon regeneration (reviewed in Ref. [4]). Whether it
occurs in healthy, mature axons in the central nervous
system was less clear.
In recent years, a surge of compelling evidence suggests
that it does happen and may even play important roles in
adult axons. In this focused review, we try summarizing
these findings with a highly simplified mechanistic model
in mind (Figure 1) hoping that obvious open questions
may reveal themselves. This model might provide one
way to explain why many mutations in RNA metabolism
are linked to human neurodegenerative diseases.
Local mRNA translation occurs in healthy
adult axons
Overall reluctance to study local translation in adult axons
was due, in part, to the scarcity of ultrastructurally iden-
tifiable polyribosomes (polysomes), the criteria of which
were established in electron microscopy (EM) studies of
non-neuronal cells (reviewed in Refs. [1,5]). Indeed,
recent evidence using RiboTag mouse [6] suggests that
ribosomes in adult axons may take a different form. In this
study, epitope-tagged ribosomes (Rpl22-HA) expressed
in retinal ganglion cells allowed ultrastructural detection
of ribosomes in fully myelinated retinal axon shafts and
presynaptic terminals. Interestingly, they were not
‘polysomal’ and existed in intermittent clusters of mono-
somes, consistent with earlier observations made in
peripheral axons [7]. These ribosomes co-purified with
specific mRNAs and ‘ran off’ the mRNAs when allowed
to continue translational elongation, indicating that co-
purified mRNAs represent the in vivo axonal translatome
(i.e. entire set of translated mRNAs). A more recent study
generalized this finding [8]. In this study using vGlut1-
EGFP transgenic mouse, ‘pre-synaptosomes’ could be
fluorescently sorted from synaptosomes, which may rep-
resent the presynaptic terminals of an ‘average’ excitatory
neuron. There, ribosomes were clearly detected by elec-
tron and super-resolution microscopy, again in sparse
clusters. Presynaptic ribosomes were slightly away from
the active zone, not unlike dendritic ribosomes that
translocate from the neck [9] to the spine upon activity
[10]. Importantly, metabolic labeling of nascent proteins
in culture showed that 30% of presynaptic terminals are
metabolically active under basal conditions, which
increases to 50% after BDNF stimulation. A similar
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Axonal RNA operon model.
See text (Section ‘Translationally co-regulated mRNAs serve common
functions: axonal RNA operons’) for details.this study, an epitope-tagged ribosomal protein (EYFP-
Rpl10A) gene, which was previously used to label axonal
ribosomes of upper motor neurons [12], was lentivirally
expressed to tag ribosomes in auditory axon terminals in
the amygdala. The mRNAs bound to these axonal ribo-
somes changed after associative fear learning, suggesting
stimulus-dependent axonal mRNA translation. Again,
polysomes were only occasionally detected in these
axons. These studies strongly suggest that axonal mRNA
translation occurs in adult axons in vivo, perhaps using
monosomes as previously proposed [1] and supported by a
recent study [13].
Protein synthetic machinery may take
different forms in axons
Another puzzling ultrastructural feature of axons is that
they appear to lack the Golgi apparatus. For this reason,
whether axonally synthesized proteins can be delivered to
the plasma membrane has been controversial, despite the
molecular evidence that axons contain transcripts encod-
ing a variety of transmembrane and secretory proteins and
the functional evidence that axons locally synthesize cell
surface receptors such as EphA2 and k-opioid receptors
(reviewed in Refs. [14,15]). A recent study shed light
upon this puzzle, by providing evidence that isolated
peripheral sensory axons can deliver subunits of the
voltage-gated sodium channel from the axonal smooth
endoplasmic reticulum (ER) to the plasma membrane
[16]. This local route may involve ‘mixed-identity
organelles’ budding off from the axonal ‘smooth’ ER,
which possess the functional and biochemical properties
of lysosomes and endosomes (reviewed in Ref. [15]).
Indeed, recent evidence suggests that axonally synthe-
sized transmembrane proteins do bypass the Golgi and
retain ‘immature’ glycosylation patterns (reviewed inCurrent Opinion in Neurobiology 2020, 63:15–22 Refs. [14,15]). Therefore, like mitochondria, whose mor-
phology is net-like in the soma and rod-like in the axon
(reviewed in Ref. [17]), protein synthetic and processing
machinery may be subcellularly specialized. In this sense,
it is worthwhile to mention that translational mechanisms
were studied mainly in the soma and therefore may have
differences in the axon. For example, cap-independent
translation may play particularly important roles [18],
although cap-dependent mechanisms also operate
[19,20]. Phosphorylation of eIF2a, which generally
decreases global translational activity and increases trans-
lation of specific mRNAs including Atf4 (reviewed in Ref.
[21] and found in axons [22]), may upregulate global
translation [23]. Intra-axonal translation may occur at
highly confined domains, such as axon branching points
[24], the surface of late endosomes [25], and the cyto-
plasmic domains of cell surface receptors [26,27].
Translationally co-regulated mRNAs serve
common functions: axonal RNA operons
An important finding is that blocking translation of one
gene produces specific phenotypes, such as cue-induced
steering and collapse of the growth cone, and elongation
and survival of axons (reviewed in Ref. [3]), suggesting
that cue-induced, mRNA-selective translation takes
place to subserve a specific function. Consistently, meta-
bolic labeling of nascent proteins in severed Xenopus
retinal axons in culture shows stimulus-dependent prote-
ome signatures [28]. To explain this mRNA-selective
translation in axons, a model [29] — sometimes entailing
coordinated regulation of multiple transcripts in an
‘operon’ — has emerged [30,31].
Akeyconcept inthismodel is thatmRNAsencodingproteins
with related functions bear a common ‘cis-element’ and are
co-stored in a translationally repressed state (Figure 1). A
trans-acting factor, for example, an RNA-binding protein
(RBP) or a microRNA, binds to and prevents the translation
of themRNAs.Thisgroup of mRNAs, or ‘RNAoperon’,may
interact with others to form a higher-order structure called
‘RNA regulon’ [31]. When a particular signal is received, a
specific RNA operon releases its target mRNAs, allowing
their translation. Functionally, axonal RNA operons should
contain 1) transcript-selective RNA binding element, 2) a
localization element, and 3) a regulatory element that reg-
ulates localization and/or translation. Biochemically, they
may simply be ‘neuronal RNA granules’ [32], whose
RNA-binding activity can be modulated.
A good example is ‘SFPQ RNA operon’ that localizes to
and supports the function of axonal mitochondria in
peripheral sensory axons [33]. SFPQ (splicing factor
proline and glutamine rich) is an RBP that can bind to
bcl2l2 and lmnb2 mRNAs encoding mitochondrially local-
ized regulators of axon survival, and to a kinesin motor.
SFPQ-containing granules deliver both mRNAs to distal
axons in a single packet, and release them uponwww.sciencedirect.com
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leads to decreased bcl2l2 and lmnb2 mRNA abundance in
axons, leading to a loss of response to neurotrophin. Other
RBPs, such as hnRNPs [34] and FMRP [35], localize to
axons, suggesting that more axonal RNA operons and
regulons await discovery. Soma-restricted RBPs such as
Pum2 keep their target mRNAs away from the axon and
indirectly shape the axonal transcriptome [36]. RBP
modification (e.g. phosphorylation) is a well-studied
mechanism that may underlie operon-selective transla-
tional activation (reviewed in Ref. [3]).
An intriguing idea is to include transmembrane receptors
in RNA operons (Figure 2). Extending the original find-
ing that DCC forms a complex with translation-stalled
ribosomes and releases them upon ligand binding [26], a
recent study generalizes this idea [27]. The receptors for
guidance cues Netrin-1 and Sema3A, which elicit oppo-
site steering responses in the growth cone, bind to ribo-
some-containing RNA granules with unique protein and
mRNA signatures. DCC and Nrp1 make complexes with
hnRNPA2/B1 and Staufen1 with respective target
mRNAs, respectively, at least in a neuronal cell line,
and these interactions are weakened by ligand binding
in cultured Xenopus retinal axons. An emerging model,
conceptually similar to G-protein-coupled receptor acti-
vation, is that ligand binding leads to a conformational
change of its receptor and subsequent release of mRNAs
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Working model and open questions.
See text for details. See section ‘Open questions’ for boxed numbers. Dash
www.sciencedirect.com translation, upon and at the site of signal reception.
Release of mRNAs might also involve direct modification
of mRNAs, for example, cleavage of 30-UTR [37].
Connection to neurodegenerative diseases:
when axonal RNA operons go wrong
What is consistent in ‘adult’ axonal transcriptome/
translatome studies is that common functions are highly
represented (Table 1). First, mRNAs encoding
‘synaptic’ proteins are enriched [8] and translated [6]
in axons in vivo. Inhibiting translation in the brain slice
that contains the calyx of Held synapse, in which pre-
synaptic ribosomes are clearly identifiable, causes a
presynaptic phenotype [38]. Secondly, mRNAs encod-
ing ‘mitochondrial’ proteins are enriched, whose local
translation is required for axon survival [33,39]. Finally,
mRNAs encoding ‘ribosomal’ proteins are abundant. Of
course, axonal translatome data are collective, and trans-
lation of these mRNA is likely to be dynamically regu-
lated in individual axons. Such a regulation is highly
relevant in understanding axon maintenance and degen-
eration, which are the topics of this and following
sections.
The idea that dysfunctional axonal mRNA translation
might be a common cause of neurodegenerative diseases
is not new (for example, see Ref. [5]). Many neurodegen-
erative diseases are thought to start with metabolic failure
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Table 1
Recent genome-wide screening studies on axonal mRNA localization and translation, relevant in understanding healthy and diseased
adult axons
Biomolecule Neuron In vivo Axon purification Detection Enriched function Ref.
RNAs (steady-state) Spinal motor (rat
embryonic culture)
– Boyden chamber RNA-seq
Mitochondrial
[50]Ribosomal
RNAs (steady-state) Spinal motor
(hiSPC-derived)
– Boyden chamber RNA-seq Mitochondrial [48]

































































Synapticretrogradely—a process known as dying-back degenera-
tion (reviewed in Refs. [40,41]). To our knowledge, the
first evidence implicating local translation in dying-back
degeneration was that inhibiting translation of lmnb2
mRNA only in axons leads to age-dependent, soma-
independent axon degeneration in Xenopus [39]. Sus-
tained local translation of lmnb2 and other related
mRNAs, perhaps from SFPQ granules [33], may be
required to maintain mitochondrial integrity and axon
health (reviewed in Ref. [17]). A defect in this process
may lead to accumulation of damaged mitochondria,
metabolic failure, and initiation of the axon destruction
pathway. The axon terminal may be particularly vulnera-
ble, because the reliance on local protein synthesis is
higher than proximal neurites. In this sense, it is note-
worthy that Nmnat2, a labile protein that should be
maintained at a certain level to suppress Sarm1-
dependent axon destruction pathway (reviewed in Ref.
[40]), is locally translated in mature axons in vivo [6].
What regulates translation of these mRNAs in healthy
axons is unknown. Exhausted mitochondria may send an
SOS to axonal mitochondrial operons (Figure 2), which
may sit on mitochondrion-docked late endosomes [25], as
cytoplasmic translation can be modulated by mitochon-
dria in yeast [42].
Biochemical studies on RBPs revealed an important
mechanistic clue that is highly relevant to neurodegener-
ative diseases [43]. Many RBPs show propensity to self-
assemble into gel and phase-separate from surrounding
liquid via the prion-like domain (or low complexity
sequence, or intrinsically disordered region) (reviewedCurrent Opinion in Neurobiology 2020, 63:15–22 in Ref. [44]) (Figure 1). This phase separation can be
regulated by biological or physical cues (e.g. phosphory-
lation or temperature), making it a novel mechanism for
mRNA-selective translational inhibition and activation.
Recent evidence suggests that this operates in axons, as
phase separation of FUS-containing granules are regu-
lated by methylation and chaperon binding in Xenopus
retinal axons [45]. If so, any mutation that makes an RBP
to gelate stronger might gradually shift the phase to
irreversible gelation, preventing translation of target
mRNAs. Again, axon terminals will be particularly vul-
nerable. A recent study using a mouse with a humanized
mutation supports this idea [46]. When the endogenous
FUS allele is replaced with a human mutation linked to
ALS/FTD (amyotrophic lateral sclerosis/frontotemporal
dementia), decreased axonal protein synthesis is the first
phenotype, which appears well before synaptic dysfunc-
tion, somal death and behavioral deficits. Importantly, it
occurs without any defects in nuclear FUS functions,
suggesting that dysfunctional axonal protein synthesis
is key to pathogenesis.
A recent study by Liao and colleagues revealed an
intriguing mechanism by which RNA granules
‘hitchhike’ lysosomes for axonal transport [47]. Annexin
11, which contains an N-terminal prion-like domain
that phase-separates and binds to RNA granules and a
C-terminal phosphoinositide binding domain that binds
to lysosomes in Ca2+-dependent manner, acts as a revers-
ible molecular tether. Intriguingly, ALS/FTD-linked
mutations in annexin 11 impairs its tethering function
and axonal transport of RNA granules, supporting thewww.sciencedirect.com
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required for long-term axon survival. Considering high
abundance and diversity of axonal mRNAs in human
motor neurons [48], it will be interesting to see whether
other ALS-linked mutations affect axonal mRNA trans-
port and/or translation. Of interest, introducing ALS-
linked mutant genes, such as Sod1G93A [49] and
Tdp43A315T [49,50], changes axonal mRNA repertoires
in cultured motor neurons.
Axonal synthesis of ribosomal proteins
A finding that has been generally overlooked is that
mRNAs encoding ribosomal proteins are abundant in
axons. In fact, they are not only abundant, but also
enriched in axons [51–53], growth cones [53,54] and
presynaptic terminals [8], and they are axonally
translated [6,28]. One potential consequence is that
axonally synthesized ribosomal proteins join axonal
ribosomes, a possibility supported by a recent study
[55]. The ribosome is an expensive organelle, whose
biogenesis involves all three RNA polymerases and
complex RNA modifications that begin in the nucleo-
lus [56]—the structure that axons clearly lack. Consid-
ering that adult axons may synthesize proteins for
years, damaged ribosomes might be better repaired
than scrapped (Figure 2). A major repair, involving
multiple ribosomal proteins, is a possibility not to be
dismissed, because the mitochondrial ribosome, whose
biogenesis is also highly complex, is indeed locally
assembled (i.e. in the axonal mitochondria) using
nuclear-encoded genes for mitochondrial ribosomal
proteins and RNA modifying enzymes [57].
Another intriguing possibility is that axonal ribosomes can
be ‘tuned’ for specific mRNAs using locally synthesized
ribosomal proteins, extending the idea of subcellular
ribosome heterogeneity (reviewed in Ref. [58]). Indeed,
distinct ribosomal proteins are locally synthesized in
axons treated with different cues [28] and might bind
ribosomes [55], although whether they join same or
different ribosomes is not known. However, the existence
of heterogenous ribosomes tuned to specific mRNAs,
perhaps docked to different receptors, is a tantalizing
idea worth serious investigation. Ribosomes could also
be tuned by RBPs such as SMN, which primes ribosomes
to mRNAs required for motor neuron function and sta-
bility [59].
Open questions
In short, mature axons coordinately translate locally
stored mRNAs to support synaptic function and long-
term survival. Mutations that perturb this process are
linked to neurodegenerative diseases in human, which
can be explained by the ‘axonal RNA operon’ model. We
end this review with open questions (Figure 2).www.sciencedirect.com mRNA transport versus translation
Most studies looked at either the transcriptome or
translatome to understand axonal mRNA translation.
To delineate mechanisms based on mRNA transport
and translation, dynamics of axonal transcriptomes in vivo
should be determined and compared with translatomes
and/or nascent proteomes. New knowledge that can be
gained from this approach includes the possibility of
mRNA recycling, which should be economical for sus-
tained translation; the existence of translationally dor-
mant mRNAs, which might play a coding-independent
role [60]; and the possibility of inter-cellular mRNA
transfer, which was previously proposed [61] and may
utilize cell-penetrating RNA-binding homeobox proteins
[62] or Arc capsids [63].
Axon targeting cis-elements
Motif analyses in axonal mRNAs have not produced easily
interpretable results, although mRNA localization is key to
protein localization [64]. Rules governing RNA localization
should be discovered, which may lie among alternatively
spliced 30-UTRs [65]. Post-transcriptional RNA modifica-
tion is an interesting possibility, as synaptosomal mRNAs
are highly N6-methyladenosine (m6A)-modified [66] and
m6A modification regulates local translation in axons
[67,68]. Other modifications, such as poly(A) addition/
removal, 30-end uridylation and pseudourydylation, are also
interesting possibilities.
Proteomics of axonally synthesized proteins
Axonally synthesized proteins may have different prop-
erties compared to those transported from the soma, such
as post-translational modification (proposed in Ref. [30])
and different C-terminal amino acids encoded in alterna-
tively spliced last exons [6,69]. Quantitative analysis of
contribution of axonally synthesized proteins to the axo-
nal proteome in vivo is also lacking. Engineered genetic
code-based techniques that allow cell type-specific met-
abolic labeling of nascent proteins [70,71] in vivo show a
promising direction.
Local translation in axon survival
Quantitative analysis of local protein synthesis in healthy,
mature axons compared to developing axons will help us
better understand its contribution to axon maintenance.
An unequivocal test on the requirement of local mRNA
translation on long-term axon survival in the mammalian
central nervous system is missing, which may require new
methods to inhibit translation only in axons in vivo.
Together, the results of the above experiments will add
important details to the model and may shed new light on
the causes and therapeutic strategies of neurodegenera-
tive diseases.
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